Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

GTBPGTBP
10 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in GT BIOPHARMA INC

GEODE CAPITAL MANAGEMENT, LLC holds 266,788 shares of GTBP (GT BIOPHARMA INC), worth $130,648 as of 2026-Q2. The position was decreased (-9.4% shares).

Current Value

$130,648

Current Shares

266,788

Total Value Change

+$80,861

Total Shares Change

+255,604

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
266,788
-9.4%
$130,6480.0%$0.49
0
2026-Q1
Increased
294,459
+1429.0%
$120,1700.0%$0.47
24
2025-Q4
Decreased
19,258
-19.6%
$15,1230.0%$0.81
0
2025-Q3
Increased
23,966
+0.5%
$14,2500.0%$0.58
12
2025-Q2
Increased
23,837
+3.3%
$85,3510.0%$3.54
15
2025-Q1
Increased
23,086
+55.0%
$51,7230.0%$2.40
20
2024-Q4
Decreased
14,899
-0.9%
$45,4570.0%$3.05
0
2024-Q3
Increased
15,041
+34.5%
$34,4530.0%$2.12
17
2024-Q2
Unchanged
11,184
0.0%
$31,6620.0%$2.83
0
2024-Q1
New
11,184
-
$49,7870.0%$4.43
31

Other major holders of GTBP: BANK OF MONTREAL /CAN/, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used